Assignee
RECRO PHARMA INC
US·5 granted patents·2 pending applications·21 citations·filing 2010–2019
Top patents by PatentIndex Score
7 records- 0188US10463673B2Nanoparticulate meloxicam formulationsRECRO PHARMA INC·Filed 2018·Granted Nov 5, 2019·4 cites·4 claims
- 0285US9795559B2Intranasal dexmedetomidine compositions and methods of use thereofRECRO PHARMA INC·Filed 2012·Granted Oct 24, 2017·17 cites·15 claims
- 0375US2020155564A1Nanoparticulate Meloxicam FormulationsRECRO PHARMA INC·Filed 2019·Application pending·0 cites
- 0464US10471067B2Nanoparticulate meloxicam formulationsRECRO PHARMA INC·Filed 2017·Granted Nov 12, 2019·0 cites·8 claims
- 0553US9078883B2Treatment or prevention of hypotension and shockRECRO PHARMA INC·Filed 2013·Granted Jul 14, 2015·0 cites·14 claims
- 0647US9446025B2Treatment or prevention of hypotension and shockRECRO PHARMA INC·Filed 2015·Granted Sep 20, 2016·0 cites·3 claims
- 0737US2011021588A1Sublingual dexmeditomidine compositions and methods of use thereofRECRO PHARMA INC·Filed 2010·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →